» Articles » PMID: 2503516

Bovine Alpha 1----3-galactosyltransferase: Isolation and Characterization of a CDNA Clone. Identification of Homologous Sequences in Human Genomic DNA

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1989 Aug 25
PMID 2503516
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

We have isolated, by immunological screening of a lambda gt11 expression library, a cDNA clone that represents the complete coding sequence for bovine alpha 1----3-galactosyltransferase. The coding sequence predicts a membrane-bound protein with three distinct structural features: a large, potentially glycosylated COOH-terminal domain (346 amino acids), a single transmembrane domain (16 amino acids), and a short NH2-terminal domain (6 amino acids). Thus, the domain structure for this transferase is similar to that deduced for beta 1----4-galactosyltransferase (Shaper, N. L., Hollis, G. F., Douglas, J. G., Kirsch, I. R., and Shaper, J. H. (1988) J. Biol. Chem. 263, 10420-10428) and alpha 2----6-sialyltransferase (Weinstein, J., Lee, E. V., McEntee, K., Lai, P.-H., and Paulson, J. C. (1987) J. Biol. Chem. 262, 17735-17743). S1 analysis demonstrates that two sets of mRNAs, which are heterogeneous at their 5' ends, are transcribed. Because both sets initiate upstream of the translational start site, only one protein is encoded by this gene. alpha 1----3-Galactosyltransferase is widely expressed in different mammalian species, with the notable exception of man and Old World monkeys (Galili, U., Shohet, S. B., Kobrin, E., Stults, C.L.M., and Macher, B. A. (1988) J. Biol. Chem. 263, 17755-17762). By Northern blot analysis we were indeed unable to detect transcripts for this enzyme in various human and Old World monkey cell lines; transcripts were readily detected in other mammalian species. However, by Southern blot analysis, homologous sequences for alpha 1----3-galactosyltransferase were identified in human genomic DNA. This suggests that the gene, although present in the human genome, is normally not expressed. These observations have potential medical implications. Because many humans have high levels of circulating antibodies directed against the enzymatic product of alpha 1----3-galactosyltransferase (Gal alpha 1----3Gal beta 1----4GlcN Ac) (Galili, U., Clark, M. R., Shohet, S. B., Buehler, J., and Macher, B. A. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 1369-1373), it has been suggested that activation of this normally silent gene may play a role in autoimmune disease in man (Etienne-Decerf, J., Malaise, M., Mahieu, P., and Winand, R. (1987) Acta Endocrinol. 115, 67-74).

Citing Articles

Self-Tumor Antigens in Solid Tumors Turned into Vaccines by α-gal Micelle Immunotherapy.

Galili U Pharmaceutics. 2024; 16(10).

PMID: 39458595 PMC: 11510312. DOI: 10.3390/pharmaceutics16101263.


Physiological basis for xenotransplantation from genetically modified pigs to humans.

Peterson L, Yacoub M, Ayares D, Yamada K, Eisenson D, Griffith B Physiol Rev. 2024; 104(3):1409-1459.

PMID: 38517040 PMC: 11390123. DOI: 10.1152/physrev.00041.2023.


Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody.

Galili U Med Res Arch. 2021; 9(7).

PMID: 34853815 PMC: 8631339. DOI: 10.18103/mra.v9i7.2481.


Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies.

Galili U Front Mol Biosci. 2021; 8:746883.

PMID: 34805272 PMC: 8601398. DOI: 10.3389/fmolb.2021.746883.


Biomanufacturing of Axon-Based Tissue Engineered Nerve Grafts Using Porcine GalSafe Neurons.

Katiyar K, Burrell J, Laimo F, Browne K, Bianchi J, Walters A Tissue Eng Part A. 2021; 27(19-20):1305-1320.

PMID: 33514288 PMC: 8610031. DOI: 10.1089/ten.TEA.2020.0303.